|
Treatment group (n = 42)
|
Control group (n = 41)
|
|
Baseline |
Week 8 |
Week 12 |
Baseline |
Week 8 |
Week 12 |
|
|
mmol/L |
mmol/L |
Triacylglycerols |
1.50 ± 0.54 |
1.33 ± 0.462,3 |
1.40 ± 0.502 |
1.61 ± 0.52 |
1.60 ± 0.59 |
1.65 ± 0.53 |
Total cholesterol |
6.47 ± 0.78 |
5.38 ± 0.802,3 |
5.43 ± 0.802,3 |
6.59 ± 0.75 |
6.57 ± 0.93 |
6.47 ± 0.93 |
HDL cholesterol |
1.29 ± 0.34 |
1.29 ± 0.34 |
1.29 ± 0.36 |
1.19 ± 0.26 |
1.19 ± 0.26 |
1.19 ± 0.28 |
LDL cholesterol |
4.47 ± 0.70 |
3.47 ± 0.702,3 |
3.49 ± 0.702,3 |
4.65 ± 0.78 |
4.63 ± 0.83 |
4.53 ± 0.85 |
|
1 x ± SD. Conversion factor to mg/dL for triacylglycerols, 0.01129; for cholesterol, 0.02586. |
2Significantly different from baseline, P < 0.05. |
3Significantly different from control group at the same week, P < 0.05. |
|